만성골수성백혈병의 임프아세포위기에서 발생한 종양용해증후군
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이덕주 | - |
dc.contributor.author | 최치언 | - |
dc.contributor.author | 이충식 | - |
dc.contributor.author | 이학현 | - |
dc.contributor.author | 박진규 | - |
dc.contributor.author | 최정혜 | - |
dc.contributor.author | 이영열 | - |
dc.contributor.author | 김인순 | - |
dc.date.accessioned | 2022-12-21T11:03:23Z | - |
dc.date.available | 2022-12-21T11:03:23Z | - |
dc.date.created | 2022-09-19 | - |
dc.date.issued | 2006-06 | - |
dc.identifier.issn | 2287-979X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/181316 | - |
dc.description.abstract | Tumor lysis syndrome (TLS) defines the metabolic derangements that occur with tumor breakdown following the initiation of cytotoxic therapy. TLS results from the rapid destruction of malignant cells and the abrupt release of intracellular materials and their metabolites into the extracellular space. The syndrome causes hyperuricemia, hyperkalemia, hyperphosphatemia, secondary hypocalcemia and uremia. It can result in acute renal failure and be fatal. Early recognition of patient at risk and preventive measures are important. There is a high incidence of TLS in tumors with high proliferative rates and large burden such as acute lymphoblastic leukemia and Burkitt's lymphoma. It less commonly occurs in solid tumors such as testicular cancer, breast cancer and small cell lung cancer. There are only complicated in CML in blast crisis. So we report a 45-yr-old woman presenting with TLS associated with CML in lymphoblastic crisis after the initiation of cytotoxic chemotherapy. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한혈액학회 | - |
dc.title | 만성골수성백혈병의 임프아세포위기에서 발생한 종양용해증후군 | - |
dc.title.alternative | Tumor Lysis Syndrome in Lymphoblastic Crisis of CML | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 박진규 | - |
dc.contributor.affiliatedAuthor | 최정혜 | - |
dc.identifier.bibliographicCitation | Blood Research, v.41, no.2, pp.8 - 8 | - |
dc.relation.isPartOf | Blood Research | - |
dc.citation.title | Blood Research | - |
dc.citation.volume | 41 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 8 | - |
dc.citation.endPage | 8 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001217170 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Tumor lysis syndrome | - |
dc.subject.keywordAuthor | Chronic myelogeous leukemia | - |
dc.subject.keywordAuthor | Blast crisis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.